PMRs and PMCs: Which Obligations Are Enforceable
Approval usually arrives with homework. It comes in two forms, and the difference is enforceability.
Postmarketing requirement (PMR). A study or trial you are required to conduct, under a statutory authority. Missing one is a violation.
Postmarketing commitment (PMC). A study you have agreed to conduct that is not required by statute. Not enforceable in the same way, but you still report on it and FDA still tracks it.
Both appear in the approval letter. Reading which is which, on the day the letter arrives, is worth doing carefully.
Where PMRs come from
FDAAA section 505(o)(3). FDA can require studies to assess a known serious risk, to assess signals of a serious risk, or to identify an unexpected serious risk when available data indicate the potential for one. This is the broadest authority and the most common source.
Accelerated approval, 21 CFR 314.510 and 601.41. Approval based on a surrogate endpoint carries a requirement to verify clinical benefit in a confirmatory trial. Failure to conduct it with due diligence is grounds for withdrawal, and FDA has withdrawn approvals on this basis.
Pediatric Research Equity Act. Required pediatric assessments.
Animal Rule, for products approved on animal efficacy data.
What the obligation actually involves
Not just running the study. Each PMR and PMC carries:
- A milestone schedule: protocol submission, study completion, final report submission. These dates are in the approval letter and FDA holds you to them.
- Annual status reporting on progress against those milestones.
- Public visibility. FDA publishes PMR and PMC status, so a delayed commitment is visible to anyone who looks.
Why they get missed
They arrive at the moment of least attention. The approval letter is a celebration, the team disperses onto the next programme, and the obligations land with whoever inherits the file.
Then the failure modes are ordinary:
- The milestone dates were negotiated by people who have left.
- The obligation sits in the approval letter and nowhere else, so no system tracks it.
- A PMC is assumed to be optional because it is not enforceable, and the annual report then has nothing to say about it.
- Nobody notices a slipping schedule until the annual status report forces the question.
Frequently asked questions
What is the difference between a PMR and a PMC?
A PMR is required under a statutory authority and is enforceable. A PMC is agreed rather than required, and is not enforceable in the same way.
What happens if I miss a PMR?
It is a violation. FDA can pursue enforcement, and for accelerated approval, failure to conduct the confirmatory trial with due diligence is grounds for withdrawing approval.
Are PMRs public?
Yes. FDA publishes the status of postmarketing requirements and commitments.
Do I have to report on a PMC?
Yes. Both PMRs and PMCs are reported on annually against their milestones.
Which authority creates most PMRs?
FDAAA section 505(o)(3), covering known serious risks, signals of serious risk, and identification of unexpected serious risks.
How does this relate to a [REMS](/glossary/rems)?
A REMS is a risk management programme required as a condition of approval. A PMR is a study obligation. A product can carry both.